slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 27,151-27,180
Pages 1,371
Rows per page 30
Component
27,151-27,180 of 41,127
30
The chart displays the count of weeks falling into specific percentage change buckets.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
31
The slide uses a color-coded bar chart approach to compare Orange's management and street estimates against a peer group of software and security companies.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
32
The slide shows a sensitivity analysis of share price based on NTM revenue multiples, comparing raw future price vs. discounted price.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
33
Includes a legend for valuation multiples and current share price; data is based on management case.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
34
Includes a table of broker targets, a stacked bar/line chart of analyst ratings vs share price, a pie chart of valuation methods, and a qualitative pros/cons matrix.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
36
The table covers CY19A through CY24E, detailing revenue, EBITDA, EBIT, and various cash flow adjustments.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown1 hit
38
Morgan Stanley project slide, likely part of a valuation or M&A deck.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
39
Share counts as of 4/6/2022 Proxy, total share count does not tie to detailed Aggregate Value build as those share counts are as of the 2Q22 filing and detailing sharecount ownership is not provided.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
40
The slide presents a WACC calculation with low, base, and high scenarios, showing inputs like Market Risk Premium, Beta, and Risk-Free Rate.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
41
Morgan Stanley | Investment Banking Pitch Book | 41 slidesMorgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
03
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
05
The slide emphasizes the 'first and only' status of the drug for these two conditions.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
10
Includes a disclaimer about the 24-month usage limit due to bone loss risk.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
Clinical trial data presentation with p-values and sample sizes.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide includes a footnote defining the response rate criteria and a disclaimer that it is not for promotion.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
The chart highlights a 74.1% mean reduction in NRS score for MYFEMBREE vs 26.4% for placebo at week 24.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
Includes clinical trial data for opioid rescue usage at baseline vs month 6.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
19
Standard pharmaceutical safety disclosure slide.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
24
The table presents efficacy percentages for MYFEMBREE vs placebo (in parentheses) for three pain metrics, plus safety data.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Beat · Solution1 hit
27
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
30
The slide uses a hub-and-spoke diagram centered on a patient photo to illustrate support services.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
31
The slide uses a visual comparison matrix to highlight the 'one pill, once-a-day' value proposition.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
32
Uses a split-screen layout to contrast 'Today' vs 'Tomorrow' strategic focus areas.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
02
NextNav | Results Presentation Deck | 11 slidesNextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Humble Origins1 hit
10
Slide 10 of a presentation deck.Nikola | Investor Day Presentation Deck | 11 slides · Nikola
Conference presentation Investor relations 1 hit
05
Includes specific pilot partner performance data in a table.Nikola | Results Presentation Deck | 22 slides · Nikola
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
02
Oatly | Results Presentation Deck | 33 slidesOatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a list format with leaf-shaped bullet points to present five key business achievements.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · Attention1 hit
24
The slide uses a custom hand-drawn aesthetic. It distinguishes between established capacity, 2021 additions, and near-term expansions.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
25
Includes forward-looking statement disclaimer and illustrative purpose note.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit